EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Considering the Risks and Costs of Solid Organ Xenotransplantation

Catharine E Krebs iD, Janine McCarthy iD, Kristie Sullivan iD, James Craner iD, Brendan Parent iD, Ann Lam iD

Advanced Biology · 2025

DOI: 10.1002/adbi.202400453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Biology, 2025. Verfasst von Catharine E Krebs und 5 weiteren Autor:innen. Beteiligte Einrichtung: Physicians Committee for Responsible Medicine, 5100 Wisconsin Ave NW, Ste 400, Washington, DC, 20016, USA. Hauptthemen laut MEDLINE: Organ Transplantation, Transplantation, Heterologous. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The standard treatment for end‐stage organ failure is transplantation, but demand for organs has always vastly outstripped supply. Discussions are ongoing about the feasibility of addressing the organ shortage through measures like increasing organ donations, improving post‐transplant outcomes, and xenotransplantation. This paper examines the rationale, risks, and costs of xenotransplantation, such as xenozoonoses, creating a new form of industrialized animal farming, abandoning animal ethics principles, and the opportunity costs of investing finite research dollars in xenotransplantation instead of investing in more viable strategies. Alternative strategies that can ethically and effectively address the demand for heart, kidney, and other transplants are recommended: Improving disease prevention and management to reduce demand for transplant organs, improving transplantation methods, and systemic changes to donor policies and organ recovery methods to increase overall supply. Upon careful exploration of the full landscape of organ transplantation, it is considered whether these alternative strategies that do not impose the definite harms and significant risks of xenotransplantation are the most ethical and effective means to increase life‐saving options and improve clinical outcomes for patients in organ failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Organ TransplantationTransplantation, HeterologousAnimalsHumansTissue and Organ Procurement

Stichwörter der Autor:innen

chronic diseaseethicshealth policyorgan supplytransplantationxenotransplantation

Autor:innen und Institutionen

  • Physicians Committee for Responsible Medicine, 5100 Wisconsin Ave NW, Ste 400, Washington, DC, 20016, USA.
  • Independent Physician, 13505 Tremolite Dr, Reno, NV, 89511, USA.
  • New York University Grossman School of Medicine, 227 E 30th Street, Ste 623, NY, NY, 10016, USA.

ORCID-Profile: Catharine E Krebs, Janine McCarthy, Kristie Sullivan, James Craner, Brendan Parent, Ann Lam

Zitieren

APA

Krebs, C. E., McCarthy, J., Sullivan, K., Craner, J., Parent, B., & Lam, A. (2025). Considering the Risks and Costs of Solid Organ Xenotransplantation. Advanced Biology. https://doi.org/10.1002/adbi.202400453

Vancouver

Krebs CE, McCarthy J, Sullivan K, Craner J, Parent B, Lam A. Considering the Risks and Costs of Solid Organ Xenotransplantation. Advanced Biology. 2025. doi:10.1002/adbi.202400453

BibTeX
@article{Krebs2025,
  author = {Krebs, Catharine E and McCarthy, Janine and Sullivan, Kristie and Craner, James and Parent, Brendan and Lam, Ann},
  title = {Considering the Risks and Costs of Solid Organ Xenotransplantation},
  journal = {Advanced Biology},
  year = {2025},
  doi = {10.1002/adbi.202400453}
}
Kostenlos starten →